Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.
Henningfield JE, Coe MA, Griffiths RR, Belouin SJ, Berger A, Coker AR, Comer SD, Heal DJ, Hendricks PS, Nichols CD, Sapienza F, Vocci FJ, Zia FZ.
Henningfield JE, et al. Among authors: belouin sj.
Neuropharmacology. 2022 Nov 1;218:109220. doi: 10.1016/j.neuropharm.2022.109220. Epub 2022 Aug 17.
Neuropharmacology. 2022.
PMID: 35987353
Free article.
Review.